Alto Neuroscience President And CFO Sold Shares Worth Over $3.5M

Alto Neuroscience, Inc. (ANRO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Alto Neuroscience Reports Second Quarter 2026 Financial Results and Recent Business Highlights – ALTO-207 development expanded: an additional Phase 3 trial evaluating ALTO-207 as monotherapy in treatment-resistant depression (TRD) is now planned, alongside the ongoin

Alto Neuroscience, Inc. (ANRO) filed an SEC Form 8-K — Results of Operations and Financial Condition. false 0001999480 0001999480 2026-07-13 2026-07-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Repor

Michael Burry reduced his bearish Caterpillar (CAT) position by 75% after his put options quadrupled in value. CAT's stock fell 10% last week but rebounded 7.2% to $598.88. Q3 revenue rose 17% to $20.7B, with earnings up to $7.20 per share. CAT's Power & Energy division saw 18% sales growth, driven by data center demand.

Boeing plans to cut 2,500 jobs (5%) in its commercial airplanes division due to slower-than-expected production increases. The division, which makes the 737 Max, lost $697 million last quarter. Layoffs will begin in December, combining attrition and involuntary cuts. Boeing's stock is down 25% in 2026.

Freedom Broker downgraded Costco (COST) to hold, raising its price target to $1,050. The stock trades near its 52-week high, with October sales up 12.6% YoY. Analysts note premium valuation but positive operating model. Other firms have mixed outlooks, with price targets ranging from $1,050 to $1,250.

Moody's assigned ratings to $758.05 million in asset-backed securities issued by GM Financial Revolving Receivables Trust 2026-1. This is the first auto loan transaction of the year from the GMREV shelf for AmeriCredit, a subsidiary of General Motors Financial Company.